Walleye Capital
AGN

Walleye Capital’s Allergan plc AGN Stock Holding History

Walleye Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,100
Closed -$690K – 2458
2019
Q3 		$690K Sell
4,100
-30,500
-88% -$4.97M 0.04% 595
2019
Q2 		$5.79M Buy
34,600
+23,700
+217% +$3.28M 0.64% 5
2019
Q1 		$1.6M Buy
+10,900
New +$1.58M 0.26% 66

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Walleye Capital's AGN Position: Q2 2020 in Review

Walleye Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 36,744 shares — an estimated $6.51M sold.

Walleye Capital first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $11.8M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Walleye Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Walleye Capital sold 36,744 Allergan plc shares in Q2 2020, an estimated $6.51M.
  • Walleye Capital first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Walleye Capital's Allergan plc position peaked at $11.8M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Walleye Capital's 13F filing for Q2 2020, filed 14 Aug 2020.